Mount Sinai Researchers Find Asian Americans to Have Significantly Higher Exposure to “Toxic Forever” Chemicals
Asian Americans have significantly higher exposure than other ethnic or racial groups to PFAS, a family of thousands of synthetic chemicals also known as “toxic forever” chemicals, Mount Sinai-led researchers report.
People frequently encounter PFAS (per- and polyfluoroalkyl substances) in everyday life, and these exposures carry potentially adverse health impacts, according to the study published in Environmental Science and Technology, in the special issue “Data Science for Advancing Environmental Science, Engineering, and Technology.”
The scientists estimated a person’s total exposure burden to PFAS and accounted for the exposure heterogeneity (for example, different diets and behaviors) of different groups of people that could expose them to different sets of PFAS. They found that Asian Americans had a significantly high PFAS exposure than all other U.S. ethnic or racial groups, and that the median exposure score for Asian Americans was 89 percent higher than for non-Hispanic whites.
This is the first time that researchers accounted for complex exposure sources of different groups of people to calculate a person’s exposure burden to PFAS. To achieve this, they used advanced psychometric and data science methods called mixture item response theory. The researchers analyzed human biomonitoring data from the U.S. National Health and Nutrition Examination Survey, a representative sample of the U.S. population.
This research suggests that biomonitoring and risk assessment should consider an exposure metric that takes into consideration the fact that different groups of people are exposed to many different sources and patterns of PFAS. Based on these findings, these researches believe that exposure sources, such as dietary sources and occupational exposure, may underlie the disparities in exposure burden. This will be an important topic of future work, as it is difficult to trace exposure sources to PFAS because they are so ubiquitous.
“We found that if we used a customized burden scoring approach, we could uncover some disparities in PFAS exposure burden across population sub-groups,” said Shelley Liu, PhD, Associate Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. “These disparities are hidden if we use a one-size-fits-all approach to quantifying everyone’s exposure burden. In order to advance precision environmental health, we need to optimally and equitably quantify exposure burden to PFAS mixtures, to ensure that our exposure burden metric used are fair and informative for all people.”
PFAS pollution is a major health concern, and nearly all Americans have detectable levels of PFAS chemicals in their blood. PFAS are ubiquitous, and are used in products that resist heat, oil, stains, grease, and water. The Biden administration has allocated $9 billion to PFAS clean-up, and in March 2023, the Environmental Protection Agency proposed the first enforceable federal standards to regulate PFAS contamination in public drinking water.
In the future, Dr. Liu’s team plans to incorporate toxicity information on each PFAS chemical into exposure burden scoring, to further evaluate disparities in toxicity-informed exposure burden in vulnerable groups and population subgroups.
The research was funded by the National Institute for Environmental Health Sciences (NIEHS) R03ES033374 and National Institute of Child Health and Human Development (NICHD) K25HD104918.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.